BiotechTube
Stem Pharm

Stem Pharm

Madison, United States· Est.
stempharm.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.8M

Overview

Founded in 2013, Stem Pharm has developed a dual-platform business focused on synthetic biomaterials and advanced human neural organoids, particularly those featuring microglia for neuroinflammatory modeling. The company operates as a private, revenue-generating CRO/platform provider, partnering with biopharma companies on neurologic drug discovery programs. Its recent recognition through a state commercialization award and published validation studies highlight the growing traction of its technology in modeling complex diseases like Alzheimer's and reducing reliance on animal testing.

Alzheimer's DiseaseNeurological Disorders

Technology Platform

Synthetic, chemically-defined biomaterials (hydrogels and coated plates) and a proprietary platform for generating advanced human neural organoids that incorporate microglia for neuroimmune and neuroinflammatory modeling.

Funding History

1
Total raised:$2.8M
Seed$2.8M

Opportunities

The growing imperative to use human-relevant, non-animal models in drug discovery creates a large and expanding market.
Stem Pharm's unique neuro-immune organoids specifically address the critical area of neuroinflammation, a key pathway in many poorly-treated neurological diseases, positioning it as a high-value partner for biopharma.

Risk Factors

The company faces technological competition in the rapidly evolving organoid field and commercial reliance on a project-based partnership model.
Adoption may be limited by the cost and complexity of its models, and regulatory acceptance of novel in vitro data for drug approval is an evolving landscape.

Competitive Landscape

Stem Pharm competes with other organoid specialists (e.g., AxoSim, Neurix) and larger life science tool companies (e.g., Thermo Fisher, Corning) offering cell culture substrates. Its key differentiation is the integrated microglia component in neural organoids, a feature not widely available, giving it an edge in neuroinflammation research.

More companies in Cell & Gene Therapy →More companies in United States →